Margaret Shipp
玛格丽特·希普
MD
Chief, Division of Hematologic Neoplasia; Professor of Medicine血液肿瘤部主任兼医学教授
👥Biography 个人简介
Margaret Shipp is a leading translational lymphoma researcher who developed the International Prognostic Index for DLBCL and contributed gene expression profiling studies defining molecular DLBCL subclasses. Her group identified PD-L1 amplification in primary mediastinal B-cell lymphoma.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
International Prognostic Index (IPI)
Led development of the IPI for aggressive NHL, the most widely used clinical prognostic tool in DLBCL management for over 30 years.
DLBCL Molecular Classification
Contributed large-scale gene expression studies defining DLBCL subgroups and identifying targetable molecular vulnerabilities.
PD-L1 in Lymphoma
Discovered recurrent 9p24.1 amplification and PD-L1 overexpression in PMBL and classical Hodgkin lymphoma, rationalizing checkpoint immunotherapy.
Representative Works 代表性著作
A predictive model for aggressive non-Hodgkin's lymphoma (IPI)
New England Journal of Medicine (1993)
Established the International Prognostic Index, the standard clinical risk stratification tool for aggressive lymphoma.
Genetic and functional characterization of PD-L1/2 in primary mediastinal large B-cell lymphoma
Blood (2016)
Identified immune evasion mechanism in PMBL and Hodgkin lymphoma, supporting PD-1 checkpoint blockade trials.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Elaine Jaffe
National Cancer Institute, NIH
Nancy Lee Harris
Massachusetts General Hospital, Harvard Medical School
Philippe Gaulard
Henri Mondor Hospital, Paris Est University
Andreas Rosenwald
University of Würzburg
关注 玛格丽特·希普 的研究动态
Follow Margaret Shipp's research updates
留下邮箱，当我们发布与 Margaret Shipp（Dana-Farber Cancer Institute, Harvard Medical School）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment